Laboratoire National de Référence-Grippes, Institut de Recherche en Sciences de la Santé (LNRG-IRSS), Ouagadougou, Burkina Faso.
Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé (IRSS-URCN), Nanoro, Burkina Faso.
Influenza Other Respir Viruses. 2024 Mar;18(3):e13271. doi: 10.1111/irv.13271.
Although influenza viruses cause only one-fifth of severe acute respiratory infections (SARI) in Burkina Faso, the other viral causes of SARI remain poorly investigated to inform clinical and preventive decision making.
Between 2016 and 2019, we prospectively enrolled inpatients meeting the World Health Organization (WHO) case definition of SARI in Burkina Faso. Results of viral etiologies among inpatients tested negative for influenza using the Fast Track Diagnostics Respiratory Kits (FTD-33) were reported.
Of 1541 specimens tested, at least one respiratory virus was detected in 76.1% of the 1231 specimens negative for influenza virus. Human rhinoviruses (hRVs) were the most detected pathogens (476; 38.7%), followed by human adenoviruses (hAdV) (17.1%, 210/1231), human respiratory syncytial virus (hRSV) (15.4%, 189/1231), enterovirus (EnV) (11.2%, 138/1231), human bocavirus (hBoV) (7.9%, 97/1231), parainfluenza 3 (hPIV3) (6.1%, 75/1231), human metapneumovirus (hMPV) (6.0%,74/1321), parainfluenza 4 (hPIV4) (4.1%, 51/1231), human coronavirus OC43 (hCoV-OC43) (3.4%, 42/1231), human coronavirus HKU1(hCoV-HKU1) (2.7%, 33/1231), human coronavirus NL63 (hCoV-NL63) (2.5%, 31/1231), parainfluenza 1 (hPIV1) (2.0%, 25/1231), parainfluenza 2 (hPIV2) (1.8%, 22/1231), human parechovirus (PeV) (1.1%, 14/1231), and human coronavirus 229E (hCoV-229E) (0.9%, 11/1231). Among SARI cases, infants aged 1-4 years were mostly affected (50.7%; 622/1231), followed by those <1 year of age (35.7%; 438/1231). Most detected pathogens had year-long circulation patterns, with seasonal peaks mainly observed during the cold and dry seasons.
Several non-influenza viruses are cause of SARI in Burkina Faso. The integration of the most common pathogens into the routine influenza surveillance system might be beneficial.
在布基纳法索,流感病毒仅导致五分之一的严重急性呼吸道感染(SARI),但其他导致 SARI 的病毒病因仍未得到充分研究,无法为临床和预防决策提供信息。
在 2016 年至 2019 年期间,我们前瞻性地招募了符合世界卫生组织(WHO)SARI 病例定义的布基纳法索住院患者。报告了使用快速通道诊断呼吸道试剂盒(FTD-33)检测流感病毒阴性的住院患者的病毒病因学结果。
在 1541 份标本中,在 1231 份流感病毒阴性标本中,至少有一种呼吸道病毒在 76.1%的标本中被检测到。人鼻病毒(hRVs)是最常见的检测病原体(476;38.7%),其次是人腺病毒(hAdV)(17.1%,210/1231)、人呼吸道合胞病毒(hRSV)(15.4%,189/1231)、肠道病毒(EnV)(11.2%,138/1231)、人博卡病毒(hBoV)(7.9%,97/1231)、副流感 3 型(hPIV3)(6.1%,75/1231)、人偏肺病毒(hMPV)(6.0%,74/1321)、副流感 4 型(hPIV4)(4.1%,51/1231)、人冠状病毒 OC43(hCoV-OC43)(3.4%,42/1231)、人冠状病毒 HKU1(hCoV-HKU1)(2.7%,33/1231)、人冠状病毒 NL63(hCoV-NL63)(2.5%,31/1231)、副流感 1 型(hPIV1)(2.0%,25/1231)、副流感 2 型(hPIV2)(1.8%,22/1231)、人副肠孤病毒(PeV)(1.1%,14/1231)和人冠状病毒 229E(hCoV-229E)(0.9%,11/1231)。在 SARI 病例中,1-4 岁的婴儿受影响最大(50.7%,622/1231),其次是<1 岁的婴儿(35.7%,438/1231)。大多数检测到的病原体全年循环,主要在寒冷干燥季节出现季节性高峰。
布基纳法索的几种非流感病毒是 SARI 的病因。将最常见的病原体纳入常规流感监测系统可能是有益的。